Classifications

• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
  • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
  • B65D5/00—Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper
  • B65D5/42—Details of containers or of foldable or erectable container blanks
  • B65D5/54—Lines of weakness to facilitate opening of container or dividing it into separate parts by cutting or tearing
  • B65D5/5495—Lines of weakness to facilitate opening of container or dividing it into separate parts by cutting or tearing for separating interconnected containers
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
  • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
  • B65D5/00—Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper
  • B65D5/42—Details of containers or of foldable or erectable container blanks
  • B65D5/4212—Information or decoration elements, e.g. content indicators, or for mailing
  • B65D5/4216—Cards, coupons or the like formed integrally with, or printed directly on, the container or lid
  • B65D5/4229—Cards, coupons or the like formed integrally with, or printed directly on, the container or lid in the form of a detachable panel
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
  • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
  • B65D5/00—Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper
  • B65D5/42—Details of containers or of foldable or erectable container blanks
  • B65D5/427—Individual packages joined together, e.g. by means of integral tabs
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
  • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
  • B65D77/00—Packages formed by enclosing articles or materials in preformed containers, e.g. boxes, cartons, sacks or bags
  • B65D77/04—Articles or materials enclosed in two or more containers disposed one within another
  • B65D77/0413—Articles or materials enclosed in two or more containers disposed one within another the inner and outer containers being rigid or semi-rigid and the outer container being of polygonal cross-section formed by folding or erecting one or more blanks, e.g. carton
  • B65D77/042—Articles or materials enclosed in two or more containers disposed one within another the inner and outer containers being rigid or semi-rigid and the outer container being of polygonal cross-section formed by folding or erecting one or more blanks, e.g. carton the inner container being of polygonal cross-section formed by folding or erecting one or more blanks, e.g. carton

Definitions

• the present invention relates to a package for at least two different products to be sold and used together. More specifically, the invention concerns a package of the above kind allowing to put on the market and to use together two or more products, said products having already been packaged singularly.
• the solution suggested according to the present invention can be used for each kind of use in the pharmaceutical, dietetic, ecc. Fields (nutraceutical, dietary supplements, ecc), such as liquid, solid (granulates, gums, tablets, capsules, bougies), hemi-solid, pressurised pharmaceutical forms, ecc.
• collateral effect can be deemed acceptable, mainly in view of advantages obtained by the main effect, in any case the user must then intake another product for preventing or reducing the above collateral effect.
• the general practitioner when the main therapy is indicated or afterwards, when the collateral reveals generally prescribes the user of the product for preventing or annulling the collateral effect.
• two products are sold separately with the pharmacy, both at the same time and separately.
• statine is for example known the importance of combining a statine with a carnitine, or any other useful drug for counterbalancing, treating or preventing the collateral effects of statine; as well as the combination of a vitamin or of a poli-vitaminic complex with an antibiotic therapy; as well as combining an anti-ulcer product with an anti-inflammatory product.
• statine is known that statine (simvastatin, lovastatin, pravastatin, fluvastatin, and their analogues) are inhibitors of hidroxi-methy-glutaril coenzyme A reductase (HMG CoA).
• statines induce a lower absorption at the intestinal level of cholesterol deriving from the diet and a reduced expression of apoproteine B present in low-density lipoproteins (LDL).
• statine are better tolerated with respect to other hypocholesterolising agents, but they have some disadvantages: the more frequent collateral effects caused by these dugs are gastrointestinal disturbs, cutaneous rushes and hemicranias.
• EP Patent 0 383 432 it is described the combination of an HMG-CoA reductase inhibitor with coenzyme Q10 for treatment of myopathia of skeletal musculature caused by statine. It has demonstrated that statine cause a reduction of mortality due to coronary cardiac pathologies, but, on the other hand, it has been registered an increase of mortality caused by other events, such as tumour or traumas, in patients subjected to the above therapy (Davey- Smith G., Song F., Sheldon T. A., Cholesterol lowering and mortality: the importance of considering initial level at risk.
• US patent n 0 4,268,524 describes a therapeutical method for increasing the high density lipoprotein (HDL) levels in such a way to selectively reduce the ratio LDL+VLDL:HDL in plasma of cardiovascular pathology risk patients, having a particularly high ratio.
• This method provides the daily administering of a dose of 5-50 mg/kg of alcanoil- carnitine or of one of its pharmaceutically acceptable salts.
• International Patent Application WO 099/01126 describes the use of alcanoil-carnitine in combination with statine for treatment of pathologies correlate with lipidic metabolism disorders.
• WO 099/01126 does not describe or suggest that L-carnitine or alcanoil L-camitine can exert a protective action on collateral effects or on toxicity induced by statine. It has been surprisingly found that the co-ordinated use of L- carnitine and one between alcanoil L-carnitine, wherein linear or branched alcanoil has between 2 and 6 carbon atoms, or one of their pharmaceutically acceptable salts, and of one statine exerts a protective action against collateral effects or toxicity caused by statine.
• L-carnitine and of one of the above aicanoil L-carnitine or of one of their pharmaceutically acceptable salts and of a statine or (ii) administering of one composition comprising the above active principles in combination and mixed, along with suitable excipients.
• Said co-administering implies also the packaged or manufactured product, in such a way to comprise the different administered forms of L-carnitine or of one of the above alcanoil L-carnitine or of one of their pharmaceutically acceptable salts and of a statine, with specific instructions for co-ordinated and simultaneous intake of the active principles according to a dosage regime set by a treatment indicated by the doctor on the basis of the patient conditions.
• the invention aims to provide a package allowing to sell and use together two (or more) different products, such as those mentioned in the above, in such a way that the user does not have the risk of not properly coupling at the moment of the purchase or during the treatment said two (or more) different products.
• a package for at least two different products, to be sold (and used) together said package providing at least one first housing for a first pre-packaged product and a second housing for a pre-packaged product, said first and second housing being coupled each other.
• said first and second housings provide a first and a second product for completing the particular therapeutical or nutritional cycle.
• said products can be liquid, solid, pharmaceutical and/or dietetic liquid, solid (granulates, gums, tablets, capsules, bougies), hemi-solid, pressurised forms, ecc.
• said housings are provided in such a way that the packages of the single products are presented side- by-side, head by head, juxtaposed, or the shoulder opposed.
• said side-by-side or head by head can be juxtaposed during their use.
• one or all said housings are provided with means for allowing the removal of price tag within the relevant packaged product, preferably a slit substantially realised in correspondence of the zone of the price tag on the product package, or lower resistance lines substantially realised in correspondence of the zone of the price tag on the product package.
• said housings can be equal each other, or they can have different shape and dimensions.
• said package can be comprised of transparent or not transparent material.
• said package can be comprised of each rigid, hemi-rigid, soft, elastic, ecc. material.
• said package can provide an opening to reach the packaged product, said opening being independent from the opening of the product package, and structurally and spatially co-ordinated with the opening of the product package, or it can be comprised of a tab foldable and fixable outside each single housing. Further, said package can be open in correspondence of the opening of the product package contained inside the same. Still according to the invention, it is possible providing instructions for using the package, said instructions being placed within a suitable pocket, or printed on the same package.
• Figure 1 shows a perspective view of a first embodiment of the package according to the invention
• Figure 2 shows a perspective view of a second embodiment of the package according to the invention
• Figure 3 shows a perspective view of a third embodiment of the package according to the invention
• Figure 4 is a bottom perspective view of the package of figure 2
• Figures 5a - 5c show the steps for folding the package according to the invention shown in figure 2
• Figure 6 is a bottom perspective view of a fourth embodiment of the package according to the invention
• Figures 7a - 7c show the steps for folding the package according to the invention shown in figure 6.
• FIG. 1 Observing first figure 1 , it is shown a package according to the invention, indicated generically by reference number 1 , providing two housings 2, 3, each having an opening similar to the opening of a standard package for drugs.
• two housings are equal, realised for two equal packaged products, being it well evident that shape and dimensions of housings 2, 3 can be of any kind, this is not a feature limiting the present invention.
• a package 4 is introduced (only one is shown in figure 1).
• the portion 5 so as to allow the contemporaneous selling of the two products, and consequently the coordinated consumption of the same products, couples two housings.
• a package 11 is shown in figure 2, provided as well with two housings 12, 13, for receiving two packaged products 14, and coupled by a part 15.
• the two housings 12, 13 are frontally opened to allow the direct insertion of the products 14.
• the product 14 packages in a traditional way.
• a package 21 provided with two housings 22, 23, for receiving two packaged products 24, said housings 22, 23 being coupled by a part 25.
• the two housings 12, 13 are frontally provided with a foldable limbo 26, having a tab 7, the end of which is coated with low adhesivity glue allowing closing and opening many times the package.
• Figure 4 is a bottom view of package 11.

Landscapes

• Engineering & Computer Science (AREA)
• Mechanical Engineering (AREA)
• Medicinal Preparation (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=34960445

Family Applications (1)

Country Status (4)

Families Citing this family (12)

Family Cites Families (14)

• 2004
  • 2004-06-23 IT IT000307A patent/ITRM20040307A1/it unknown
• 2005
  • 2005-01-31 US US11/570,833 patent/US20080272021A1/en not_active Abandoned
  • 2005-01-31 EP EP05709194A patent/EP1758794A1/de not_active Withdrawn
  • 2005-01-31 WO PCT/IT2005/000044 patent/WO2006001039A1/en active Application Filing

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events